Lesson 4 of 10 · 18 min

Stem cells, mitosis and differentiation

Describe how stem cells arise by mitosis and differentiate into specialised cells, classify them as totipotent, pluripotent, multipotent or unipotent, and weigh the safety, ethics and efficacy of stem cell technologies.

What you will be able to do

  • Describe how mitosis produces genetically identical cells, and how stem cells self-renew and differentiate.
  • Explain that differentiation happens by switching genes on and off, not by losing genes.
  • Distinguish totipotent, pluripotent, multipotent and unipotent stem cells, with an example of each.
  • Describe how cells are reprogrammed to become pluripotent, and evaluate the safety, ethics and efficacy of stem cell technologies.

You began as a single cell, a fertilised egg (zygote) about 0.1 mm across. Today you are made of tens of trillions of cells of a couple of hundred different kinds: neurons a metre long, red blood cells without a nucleus, muscle fibres that contract, cells that secrete acid into your stomach. Every one of them came from that zygote by cell division, and every one carries the same DNA. So how did they become so different?

Definition

Stem cell

A stem cell is an unspecialised cell that can

  1. divide by mitosis to make more stem cells (self-renewal), and
  2. differentiate: develop into specialised cells.

Specialised cells usually divide rarely or not at all, so stem cells are the body's source of new cells for growth and repair.

Mitosis. Before a cell divides it copies (replicates) every chromosome. In mitosis the copies are separated so that each new nucleus receives one complete set. The cytoplasm then divides (cytokinesis), giving two daughter cells that are genetically identical to each other and to the parent cell, with the same number of chromosomes.

Mitosis has four stages:

  • Prophase: the copied chromosomes condense and become visible, each as two identical sister chromatids joined at the centromere; the nuclear envelope breaks down.
  • Metaphase: spindle fibres line the chromosomes up across the middle of the cell.
  • Anaphase: the sister chromatids are pulled apart to opposite ends of the cell.
  • Telophase: a nuclear envelope forms around each set of chromosomes.

Put these events of cell division in order.

Drag the handles, or use the arrow buttons, to put these in order.

  1. The chromosomes line up across the middle of the cell (metaphase).
  2. The cytoplasm divides into two cells (cytokinesis).
  3. The chromosomes condense and the nuclear envelope breaks down (prophase).
  4. Sister chromatids are pulled to opposite ends of the cell (anaphase).
  5. Two new nuclear envelopes form (telophase).
  6. The chromosomes are copied (replicated).

How stem cells originate and renew. When a stem cell divides by mitosis, one daughter cell often stays a stem cell while the other begins to differentiate. In this way the supply of stem cells is kept up while new specialised cells are made. The zygote is the first stem cell of all; every other stem cell in your body comes from it by mitosis.

Key idea

Differentiation is gene expression

Every cell made by mitosis has the same genes. A cell differentiates by switching particular genes on and others off. The genes that are on decide which proteins the cell makes, and those proteins give it its structure and function: haemoglobin in a developing red blood cell, contractile proteins in a muscle cell, digestive enzymes in a pancreatic cell.

So a neuron and a skin cell from the same person contain identical DNA; they differ in which genes they use. Specialised cells of the same type then group together to form tissues.

Common mistake

Cells don't lose genes as they specialise

Students sometimes write that a muscle cell "only has muscle genes". It has every gene; most are switched off. (Mature mammalian red blood cells are an exception: they lose their whole nucleus.) The evidence comes from cloning: in 1962 John Gurdon grew tadpoles from frog eggs whose own nucleus had been replaced with one from a tadpole's specialised intestinal cell.

Potency. Stem cells differ in how many kinds of cell they can become, their potency. As an embryo develops, its cells' potency narrows step by step.

The four levels of potency
PotencyCan becomeExamples
TotipotentAny cell of the body and the placenta and membranes around the embryo: a whole organismThe zygote and the cells of the first few divisions (up to about the 8-cell stage)
PluripotentAny cell of the body (from all three germ layers), but not the placentaEmbryonic stem cells from the inner cell mass of a 5-day blastocyst; induced pluripotent stem (iPS) cells
MultipotentSeveral related cell types, within one tissue or familyHaematopoietic stem cells in bone marrow (all the blood cells: red, white, platelets); mesenchymal stem cells (bone, cartilage, fat); neural stem cells (neurons and glial cells)
UnipotentOnly one cell type (while still renewing themselves)Spermatogonial stem cells (sperm); muscle satellite cells (skeletal muscle fibres); basal cells of the epidermis (keratinocytes)
Interactive

From zygote to specialised cell

Pick a cell to see what it can become, and follow a lineage from the zygote. Then run the reprogramming of a skin cell back to an iPS cell.

Tip

Remember the order

Totipotent: total, everything including the placenta. Pluripotent: plural, many, all body cells. Multipotent: several in one family. Unipotent: one. Potency falls in that order as development goes on.

Stem cells in bone marrow produce red blood cells, several kinds of white blood cell and platelets, but no other cell types. How would you classify them?

Choose one answer

Worked example

Classify stem cells by potency

  • Simple familiar
  • Technology free

Classify each cell as totipotent, pluripotent, multipotent or unipotent, and justify each answer.

(a) A cell from a human embryo at the 4-cell stage. (b) A cell from the inner cell mass of a 5-day blastocyst. (c) A stem cell in the bone marrow that gives rise to red blood cells, white blood cells and platelets. (d) A stem cell in the testis that produces only sperm.

4 steps

Try it yourself first, then check the working one step at a time.

Method

  1. Ask what the cell can become: everything including the placenta (totipotent), any body cell (pluripotent), several related types (multipotent), or one (unipotent).

  2. Embryonic stage: the earlier, the greater the potency.

Watch out for

  • Calling embryonic stem cells totipotent. They cannot form the placenta.

Reprogramming cells. For decades the only source of pluripotent human cells was the inner cell mass of early embryos, left over from IVF and donated for research, which destroys the embryo. In 2006 Kazutoshi Takahashi and Shinya Yamanaka in Kyoto showed that adding just four genes (Oct3/4, Sox2, Klf4 and c-Myc) to mouse skin cells (fibroblasts) reprogrammed them into pluripotent cells. In 2007 Yamanaka's group, and separately James Thomson's group in the USA, did the same with human cells. These are induced pluripotent stem cells (iPS cells). Yamanaka shared the 2012 Nobel Prize in Physiology or Medicine with John Gurdon "for the discovery that mature cells can be reprogrammed to become pluripotent".

Because iPS cells are pluripotent, they can in principle be grown into any specialised cell to repair or replace damaged tissue. Made from a patient's own skin or blood cells, they carry the patient's own genes. In 2014 a team at the RIKEN institute in Japan led by Masayo Takahashi transplanted the first tissue made from iPS cells, a sheet of retinal cells, into a woman with age-related macular degeneration.

Weighing up stem cell technologies
AspectConsiderations
SafetyLeftover pluripotent cells can grow into tumours (teratomas); one reprogramming gene, c-Myc, can cause cancer, so newer methods avoid it. Cells from a donor can be rejected by the immune system, which iPS cells made from the patient avoid. Long culture can introduce mutations. Unproven "stem cell" treatments sold by some clinics have caused serious harm.
EthicsEmbryonic stem cells require the destruction of an early human embryo, which some people consider has moral status; iPS cells avoid this. In Australia, research on donated excess IVF embryos needs a licence from the NHMRC under the Research Involving Human Embryos Act 2002. Other issues: informed consent of donors, cost and fair access, and misleading advertising.
EfficacyHaematopoietic (bone marrow) stem cell transplants are a proven treatment for leukaemia and other blood disorders, used since the late 1960s. Most other uses, including iPS-derived tissues, are still in clinical trials: they have to show that the transplanted cells survive, integrate, work and are safe in many patients.

Give two advantages of using iPS cells made from a patient's own skin cells, rather than embryonic stem cells, to grow replacement tissue for that patient.

Write it out as you would in an exam. Put maths between dollar signs, like $x^2 + 1$. Worth 1 mark.

0 / 4000

Worked example

Evaluate an iPS cell therapy for macular degeneration

  • Complex unfamiliar
  • Technology free

In age-related macular degeneration, a layer of cells behind the retina (the retinal pigment epithelium) dies and central vision is lost. In 2014 researchers in Japan took skin cells from a patient, reprogrammed them into iPS cells, grew them into a sheet of retinal pigment epithelium and transplanted it into her eye. A year later the sheet was still in place, there was no sign of rejection or tumours, and her vision had stopped getting worse, though it had not improved.

Evaluate the use of iPS cells for this treatment, considering its safety, ethics and efficacy.

5 steps

Try it yourself first, then check the working one step at a time.

Method

  1. Explain the relevant biology briefly (what iPS cells are).

  2. Give points for and against under safety, ethics and efficacy, each specific to the case.

  3. Comment on the strength of the evidence (sample size, follow-up time).

  4. Finish with a reasoned judgement.

Watch out for

  • Listing advantages and disadvantages without a final judgement.

  • Treating one successful case as proof that the treatment works.

Exam tip

Evaluating a technology

An "evaluate" question on stem cells wants both sides and a judgement. Organise your answer under the three headings the syllabus uses, safety, ethics and efficacy, with a specific point for each ("residual pluripotent cells can form tumours"), and finish with a reasoned conclusion ("promising, but not yet proven safe in large trials").

Summary

  • Mitosis produces two genetically identical daughter cells; stem cells divide by mitosis to renew themselves and to supply cells that differentiate.

  • Differentiation is switching genes on and off: every specialised cell has the same DNA but makes different proteins.

  • Totipotent: everything including the placenta (zygote, first few divisions). Pluripotent: any body cell (embryonic stem cells, iPS cells).

  • Multipotent: several related types (haematopoietic stem cells make all blood cells). Unipotent: one type (spermatogonial stem cells).

  • iPS cells are specialised cells reprogrammed to pluripotency (Takahashi and Yamanaka, 2006); they could replace damaged tissue without rejection or destroying embryos.

  • Judge stem cell technologies on safety (tumours, rejection), ethics (embryos, consent, access) and efficacy (proven for blood disorders, otherwise mostly in trials).

Finished the lesson?

Try the 3 quick checks above and the lesson completes itself, or mark it complete now.

Lesson 4 of 100% read

Save your progress with a free account